Similar Articles |
|
Chemistry World July 10, 2012 Phillip Broadwith |
Silky solution to storing vaccines and drugs Storing delicate vaccines and antibiotics in freeze-dried silk could eliminate the need for refrigerated storage, reducing transport costs and waste, say US researchers. |
Home Toys April 2005 Frank Geissler |
Now, Your Home Will Call You When There's a Problem While away, temperatures in your home or business will be carefully monitored, and you will automatically be notified via telephone whenever there is a dramatic on-site change in ambient temperature or other conditions. |
Pharmaceutical Executive May 1, 2006 Pasternak et al. |
Vaccines: Market on the Rebound The vaccine business was safely inoculated against higher profits. But innovative therapies and looser government controls may spark an outbreak. Are pharmaceuticals ready for this opportunity? |
American Family Physician December 1, 2002 Sanford R. Kimmel |
Vaccine Adverse Events: Separating Myth from Reality Vaccines have turned many childhood diseases into distant memories in industrialized countries. However, questions have been raised about the safety of some vaccines because of rare but serious adverse effects that have been attributed to them. |
Salon.com March 8, 2001 Amy Standen |
Ready for some lockjaw? There's no profit in the tetanus vaccine business, so a rare and hideous disease may soon strike more Americans... |
American Family Physician August 15, 2004 Huggins & Looney |
Allergen Immunotherapy The major objectives of the practice are to reduce responses to allergic triggers that precipitate symptoms in the short term and to decrease inflammatory response and prevent development of persistent disease in the long term. |
Pharmaceutical Executive June 1, 2013 Tom Reynolds |
Finding Strategic Levers in the Supply Chain Customer-focused supply-chain capabilities are becoming a more important part of a company's competitive advantage. |
IndustryWeek November 1, 2008 David Blanchard |
A Healthier Supply Chain: By the Numbers UPS, along with Harris Interactive, recently conducted a "pain in the supply chain" survey of pharmaceutical, biotech, medical and surgical device manufacturers. Some of the key findings of the survey are listed here. |
American Family Physician July 15, 2003 Sur et al. |
Vaccinations in Pregnancy Routine vaccines that generally are safe to administer during pregnancy include diphtheria, tetanus, influenza, and hepatitis B. Other vaccines, such as meningococcal and rabies, may be considered. |
Pharmaceutical Executive February 1, 2009 Joanna Breitstein |
Vaccines for All The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most. |
Popular Mechanics December 2009 Seth Porges |
Does Cold Weather Injure Cell Phones? Abusive Lab Test Exactly how cold can a phone get before it stops working? We decided to find out. |
American Journal of Nursing July 2008 Kiekkas et al. |
Physical Antipyresis in Critically Ill Adults Nurses use a variety of methods to cool critically ill patients, even though there are no guidelines for the treatment of temperature elevation in this population. |
Popular Mechanics February 11, 2010 Adam Hadhazy |
The Truth About 9 Anti-Vaccine Studies Led by celebrities such as Jenny McCarthy, the anti-vaccine movement continues to vehemently oppose mainstream science's overwhelming consensus that vaccines do not cause developmental disorders. |
Managed Care January 2008 Martin Sipkoff |
Should Pharmacists Be Allowed To Vaccinate Their Patients? Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment. |
National Defense November 2005 Margaret Davidson |
Biodefense Experts: Vaccines `At a Crossroads' Many of the companies seeking government funds for biodefense work are small firms with no experience in bringing a drug to market. And they face a significant challenge. |
InternetNews July 27, 2010 |
Oracle Debuts Drug-Tracking App for Big Pharma With its new Pedigree and Serialization Manager, Oracle is pitching an application to pharmaceutical companies that will enable them to track the movement of drugs across the supply chain. |
Pharmaceutical Executive April 1, 2014 William Looney |
The Trials of Commerce Four commercial line executives serve as our jury of peers on what's in store for the future of pharma, and discuss the changing criteria for market success, from drugs to consumer products to vaccines. |
Pharmaceutical Executive September 1, 2005 Wolfgang Klietmann |
Thought Leader: (Eco)systemic Change The author discusses how various players within the healthcare system interact. |
American Family Physician July 1, 2000 Monica Preboth |
Practice Guidelines ACIP Issues Recommendations for the 2000-2001 Influenza Season |
American Family Physician August 15, 2000 Rosemarie Sweeney & Toni Lapp |
Newsletter Major Insurers Announce Health Plan Changes... NIAID Will Fund HIV Vaccine Trials Network... Safeguards Needed to Protect Children from Dosing Errors... Study Finds Increase in Physicians' Use of E-mail... ISMP to Publish Dosing Corrections on Its Web Site... Prescription Drug Spending Increased 17.4 Percent in 1999 |
American Family Physician May 15, 2001 |
Pneumococcal Conjugate Vaccine: What a Parent Needs to Know Why should my child get this vaccine?... What exactly is the pneumococcal vaccine?... Are there some children who should not get pneumococcal conjugate vaccine or who should wait until they are older?... |
Pharmaceutical Executive July 3, 2007 Jill Wechsler |
Washington Report: Vaccines for Everyone New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access, and to bring necessary medications to third-world countries. |
Pharmaceutical Executive July 10, 2014 Fitzpatrick & Mohan |
Vaccines: Fire in the Cold Chain It's only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance. |
Pharmaceutical Executive April 1, 2012 Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
American Family Physician September 1, 2003 Maurer et al. |
Smallpox Vaccine: Contraindications, Administration, and Adverse Reactions Public health departments and the U.S. military have begun the process of vaccinating soldiers and civilian first-responders. Smallpox vaccination carries some serious risks. |
American Family Physician August 15, 2004 |
Newsletter CMS Issues Notice Warning Physicians to Protect Medicare Provider Identification Numbers from Fraudulent Employees... Veterans Returning from Combat Zones Rely on Family Physicians for Mental Health Screening... etc. |
Pharmaceutical Executive July 3, 2007 LeVine & Zucker |
Marketing to Professionals: Professional Promotion Through Patient Understanding Patient-feedback programs can go a long way in helping physicians understand which drugs work. |
Knowledge@Wharton August 27, 2003 |
Code Blue: Combating Rising Healthcare Costs Calls for Strong Medicine It's been said many times over that the U.S. healthcare industry is a sick patient in search of a cure. The metaphor is a grim reflection of how the country is coping with an aging population, rising costs and an inefficient healthcare delivery system. |
The Motley Fool September 25, 2007 Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
Managed Care October 2000 Kevin A. Wilson |
Public Policy Largely Ignores Adult Immunization Needs Although four fifths of the nation's children are fully immunized, tens of thousands of adults die each year from diseases preventable by vaccination... |
American Family Physician June 1, 2002 Randell K. Wexler |
Evaluation and Treatment of Heat-Related Illnesses Although athletes are commonly thought to be most at risk for heat illnesses, children and the elderly are particularly vulnerable. It is important to be vigilant for heat illnesses because they occur insidiously but progress rapidly. |
Managed Care June 2005 Martin Sipkoff |
The Re-Emergence of the Primary Care Physician A new model of care developed by the American Academy of Family Physicians places primary care physicians back at the center of care delivery. |
American Family Physician July 1, 2004 Lo Re & Gluckman |
Travel Immunizations The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before trip departure, and current knowledge of the epidemiology of vaccine-preventable diseases. |
Health October 2007 Sarah Clachar |
Read this BEFORE you get a flu shot The flu vaccine may not be as good -- or as safe -- as you think. |
Pharmaceutical Executive March 1, 2011 Jerry Coamey |
Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution |
Bio-IT World Dec 2005/Jan 2006 Salvatore Salamone |
Gates, Clinton Address Global Health Summit The conference brought together leaders in business, government, medicine, public philanthropic groups, and the arts to address and develop solutions to the world's heath crises. |
CIO July 31, 2015 Tom Kaneshige |
The Internet of Things now includes the grocery store's frozen-food aisle Supermarket giant Kroger uses temperature sensors to keep frozen foods frozen -- and makes its first foray into the Internet of Things. |
Chemistry World March 17, 2011 Hepeng Jia |
International recognition helps Chinese vaccine industry Vaccines made in China will now be supplied through United Nations agencies to developing countries, after recognition from the World Health Organisation that China's State Food and Drug Administration has complied with international standards for vaccine regulation. |
Pharmaceutical Executive August 1, 2012 |
Sunny Outlook for Biopharm 2020? Albert Wertheimer looks beyond today's dark clouds with a comparatively sunny forecast for the biopharm industry in 2020. Just watch out for the harsh light of complacency. |
Scientific American February 2006 |
To Banish a Cancer Two vaccines that are nearing approval by the Food and Drug Administration in the U.S. have demonstrated in clinical trials that they can prevent infection from the two types of the human papillomavirus (HPV) that account for up to 70 percent of cervical cancers. |
Pharmaceutical Executive December 1, 2005 Anthony Tao |
The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray? Small profit margins and high litigation risks drove most companies out of the vaccine business decades ago. As a possible pandemic looms, pharma re-enters the fray. Is it too late? |
The Motley Fool December 19, 2005 Brian Gorman |
Developing Drug Markets Drug companies focusing on the developing world could see major payoffs. Asia, Africa, and Australia offer very significant opportunities for investors. |
Chemistry World December 3, 2014 Maria Burke |
Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline. |
Managed Care April 2000 Tim Olsen |
Physician, Tarnish Not Thine Image Doctors who use the news media to criticize others, rather than initiate a constructive dialog about difficult issues such as antibiotic resistance, help erode the profession's influence. |
The Motley Fool January 11, 2005 Charly Travers |
The Future of Cancer Vaccines Biotech companies developing cancer vaccines have been in investors' doghouses for a long time. Can a vaccine help stave off forms of the disease? |
The Motley Fool July 22, 2005 Karl Thiel |
Cancer Drug: A Shot at Success Cancer vaccine pioneer Dendreon delivered news yesterday that its investors have been anxiously awaiting: final three-year survival data from a phase 3 study of Provenge, the company's flagship prostate cancer vaccine. |
Pharmaceutical Executive January 1, 2013 Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
HBS Working Knowledge March 1, 2004 Martha Lagace |
Injecting New Life into the Vaccine Industry Vaccines for preventable diseases save millions of lives every year, yet as an industry, the vaccine business suffers a host of ailments, the CEO of Merck & Co. contends. |
Chemistry World February 7, 2008 Hepeng Jia |
Profile: Vaccine Trailblazer Yin Weidong is one of the leading lights of China's fast growing biotech industry and Sinovac the first Chinese biotech firm listed on the US stock exchange. |
American Family Physician October 15, 2004 Genevieve Ressel |
Newsletter Vaccine Manufacturer Expecting Delays in Distribution of Fluvirin... U.S. Census Bureau Report Confirms Rising Number of Uninsured Americans... CDC Reminds Physicians to Consider West Nile Virus in Pregnant Women... etc. |